Evidence map›Paper›PMID 31809523›Full record

ArticlePLoS pathogens2019

Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa.

Nuno R Faria, Nicole Vidal, José Lourenco, Jayna Raghwani, Kim C E Sigaloff, Andy J Tatem, David A M van de Vijver, Andrea-Clemencia Pineda-Peña, Rebecca Rose, Carole L Wallis and 12 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Revisiting the recombinant history of HIV-1 group M with dynamic network community detection.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Nuno R FariaDepartment of Zoology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-8839-2798
Nicole VidalTransVIHMI, Institut de Recherche pour le Développement, INSERM, and University of Montpellier, Montpellier, France.ORCID 0000-0001-7022-2643
José LourencoDepartment of Zoology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-9318-2581
Jayna RaghwaniDepartment of Zoology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-8538-4995
Kim C E SigaloffAmsterdam Institute for Global Health and Development, Department of Global Health, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Andy J TatemDepartment of Geography and Environment, University of Southampton, Southampton, United Kingdom.
David A M van de VijverViroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands.
Andrea-Clemencia Pineda-PeñaGlobal Health and Tropical Medicine-Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal.
Rebecca RoseBioinfoexperts, LLC, Thibodaux, Los Angeles, United States of America.
Carole L WallisDepartment of Molecular Pathology, Lancet Laboratories and BARC-SA, Johannesburg, South Africa.
Steve Ahuka-MundekeInstitut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo and Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of Congo.
Jean-Jacques Muyembe-TamfumInstitut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo and Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of Congo.
Jérémie MuwongaAIDS national laboratory and Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of Congo.ORCID 0000-0002-0800-6146
Marc A SuchardDepartments of Biomathematics and Human Genetics David Geffen School of Medicine at UCLA, and Department of Biostatistics UCLA School of Public Health, Los Angeles, United States of America.ORCID 0000-0001-9818-479X
Tobias F Rinke de WitAmsterdam Institute for Global Health and Development, Department of Global Health, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Raph L HamersAmsterdam Institute for Global Health and Development, Department of Global Health, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-5007-7896
Nicaise NdembiInstitute of Human Virology, Abuja, Nigeria.
Guy BaeleKU Leuven, Department of Microbiology and Immunology, Rega Institute, Laboratory for Clinical and Epidemiological Virology, Leuven, Belgium.ORCID 0000-0002-1915-7732
Martine PeetersTransVIHMI, Institut de Recherche pour le Développement, INSERM, and University of Montpellier, Montpellier, France.
Oliver G PybusDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Philippe LemeyKU Leuven, Department of Microbiology and Immunology, Rega Institute, Laboratory for Clinical and Epidemiological Virology, Leuven, Belgium.ORCID 0000-0003-2826-5353
Simon DellicourKU Leuven, Department of Microbiology and Immunology, Rega Institute, Laboratory for Clinical and Epidemiological Virology, Leuven, Belgium.ORCID 0000-0001-9558-1052

Funding

Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Bryan Briney · 2018 to 2026
$32.0M
BAYESIAN MODELING AND DATA INTEGRATION IN INFECTIOUS DISEASE PHYLODYNAMICSR01AI107034 · NIAID · UNIVERSITY OF WASHINGTON · PI MININ, VOLODYMYR · 2013 to 2017
$1.7M
NIAID NIH HHS R01 AI107034NIAID NIH HHS U19 AI135995Wellcome TrustWellcome Trust 106866/Z/15/ZWellcome Trust 204311/Z/16/ZWellcome Trust 204613/Z/16/ZWellcome Trust 206298/Z/17/Z
6 · The paper itself

Abstract

Since the ignition of the HIV-1 group M pandemic in the beginning of the 20th century, group M lineages have spread heterogeneously throughout the world. Subtype C spread rapidly through sub-Saharan Africa and is currently the dominant HIV lineage worldwide. Yet the epidemiological and evolutionary circumstances that contributed to its epidemiological expansion remain poorly understood. Here, we analyse 346 novel pol sequences from the DRC to compare the evolutionary dynamics of the main HIV-1 lineages, subtypes A1, C and D. Our results place the origins of subtype C in the 1950s in Mbuji-Mayi, the mining city of southern DRC, while subtypes A1 and D emerged in the capital city of Kinshasa, and subtypes H and J in the less accessible port city of Matadi. Following a 15-year period of local transmission in southern DRC, we find that subtype C spread at least three-fold faster than other subtypes circulating in Central and East Africa. In conclusion, our results shed light on the origins of HIV-1 main lineages and suggest that socio-historical rather than evolutionary factors may have determined the epidemiological fate of subtype C in sub-Saharan Africa.

Indexed as

Africa, CentralAfrica, EasternHIV-1HIV InfectionsHumans

Identifiers

PMID31809523
PMCPMC6897401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.